Oramed Pharmaceuticals's top three insider shareholders as of September 29, 2026 are Nadav Kidron (President And Ceo, 4.14Mn shares), Miriam Kidron (Chief Scientific Officer, 1.55Mn shares), Joshua Hexter (Coo Cbo, 1.36Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Nadav Kidron | President And Ceo | 4,140,505 | 0 | 4,140,505 | 43.5% | 25 Sep, 2026 |
| 2 | Miriam Kidron | Chief Scientific Officer | 1,550,554 | 0 | 1,550,554 | 16.3% | 25 Sep, 2026 |
| 3 | Joshua Hexter | Coo Cbo | 1,358,130 | 0 | 1,358,130 | 14.3% | 25 Sep, 2026 |
| 4 | Avraham Gabay | Chief Financial Officer | 881,076 | 0 | 881,076 | 9.2% | 25 Sep, 2026 |
| 5 | David Silberman | Chief Financial Officer | 366,500 | 0 | 366,500 | 3.8% | 08 Jan, 2024 |
| 6 | Arie Mayer | Director | 168,009 | 0 | 168,009 | 1.8% | 05 Jan, 2026 |
| 7 | Yadin Rozov | Director | 155,320 | 0 | 155,320 | 1.6% | 08 Jan, 2024 |
| 8 | Netanel Derovan | Chief Legal Officer | 149,500 | 0 | 149,500 | 1.6% | 31 May, 2023 |
| 9 | Leonard Sank | Director | 134,531 | 0 | 134,531 | 1.4% | 09 Jun, 2025 |
| 10 | Michael Rabinowitz | Chief Commercial Officer | 126,143 | 0 | 126,143 | 1.3% | 04 Jan, 2023 |
| 11 | Benjamin Shapiro | Director | 123,220 | 0 | 123,220 | 1.3% | 05 Jan, 2026 |
| 12 | Daniel Aghion | Director | 113,441 | 0 | 113,441 | 1.2% | 02 Jan, 2026 |
| 13 | Michael Rabinowitz | Chief Commercial Officer | 109,468 | 0 | 109,468 | 1.1% | 05 Jan, 2022 |
| 14 | Yehuda Reznick | Director | 105,180 | 0 | 105,180 | 1.1% | 05 Jan, 2026 |
| 15 | Kevin Rakin | Director | 46,661 | 0 | 46,661 | 0.5% | 22 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 24 Sep, 2026 | Joshua Hexter | Coo Cbo | Acquired A | 75,455 | — | — | 1,148,839 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Acquired A | 208,125 | — | — | 1,341,263 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Acquired A | 349,497 | — | — | 3,771,740 | Direct |
| 24 Sep, 2026 | Avraham Gabay | Chief Financial Officer | Acquired A | 209,291 | — | — | 881,076 | Direct |
| 24 Sep, 2026 | Joshua Hexter | Coo Cbo | Acquired A | 209,291 | — | — | 1,358,130 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Acquired A | 209,291 | — | — | 1,550,554 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Acquired A | 368,765 | — | — | 4,140,505 | Direct |
| 24 Sep, 2026 | Joshua Hexter | Coo Cbo | Disposed D | 50,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 104,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 100,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Disposed D | 196,500 | — | — | 0 | Direct |
| 24 Sep, 2026 | Joshua Hexter | Coo Cbo | Disposed D | 50,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Joshua Hexter | Coo Cbo | Disposed D | 36,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Disposed D | 190,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 69,999 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 47,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Disposed D | 49,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 100,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Nadav Kidron | President And Ceo | Disposed D | 97,000 | — | — | 0 | Direct |
| 24 Sep, 2026 | Miriam Kidron | Chief Scientific Officer | Disposed D | 72,000 | — | — | 0 | Direct |